Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity
Open Access
- 19 December 2022
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 479 (24), 2465-2475
- https://doi.org/10.1042/bcj20220472
Abstract
The Epidermal Growth Factor Receptor (EGFR) is a Receptor Tyrosine Kinase that mediates cell proliferation and differentiation events during development and maintenance of complex organisms. Formation of specific, ligand-dependent EGFR dimers is a key step in stimulating EGFR signaling, and crystal structures of active, dimeric forms of isolated EGFR extracellular regions and kinase domains have revealed much about how dimer interactions regulate EGFR activity. The nature and role of the transmembrane region in regulating EGFR activity remains less clear, however. Proposed roles for the transmembrane region range from nonspecific but energetically favorable interactions to specific transmembrane dimer conformations being associated with active, inactive, or activity-modulated states of EGFR. To investigate the role of specific transmembrane dimers in modulating EGFR activity we generated thirteen EGFR variants with altered transmembrane sequences designed to favor or disfavor specific types of transmembrane region interactions. We show using FRET microscopy that EGFR transmembrane regions have an intrinsic propensity to associate in mammalian cell membranes that is counteracted by the extracellular region. We show using cell-based assays that each of the EGFR transmembrane variants except the Neu variant, which results in constitutive receptor phosphorylation, is able to autophosphorylate and stimulate phosphorylation of downstream effectors Erk and Akt. Our results indicate that many transmembrane sequences, including polyleucine, are compatible with EGFR activity and provide no evidence for specific transmembrane dimers regulating EGFR function.This publication has 48 references indexed in Scilit:
- Conformational Coupling across the Plasma Membrane in Activation of the EGF ReceptorCell, 2013
- Transmembrane helix dimerization: Beyond the search for sequence motifsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Regulation of the catalytic activity of the EGF receptorCurrent Opinion in Structural Biology, 2011
- Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3Proceedings of the National Academy of Sciences of the United States of America, 2009
- Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane SegmentCell, 2009
- Targeting the function of the HER2 oncogene in human cancer therapeuticsOncogene, 2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor αCell, 2002